Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Cannabis offers exit ramp from alcohol, opioid addiction

Cannabis has been labeled a “gateway," but recent research shows marijuana may be more of an exit drug for people with addiction problems while also improving mental health.

Juno Biomedical develops treatment for stroke patients to regain motor function

Juno Biomedical has announced the partnership with Promenade Software to further develop software for Juno Biomedical's CELLTech device, which uses 30 years of cell electrotaxis research to create a device that helps stroke patients regain motor function.

Blood tests indicate Zika still rare in US

As U.S. blood banks begin testing for the Zika virus, early results are showing that it remains rare, according to a recent report from The New York Times.

ACA risk corridor lawsuit tossed out

Land of Lincoln Health, a now-shuttered Illinois health insurance co-op, lost its legal fight with HHS after a federal judge threw out its lawsuit over payments it claimed to be owed under the Affordable Care Act’s risk corridor program.

How drug price hikes affect Medicare, Medicaid

Steep price hikes for a number of prescription drugs led to big increases in Medicaid and Medicare spending in 2015, according to data released by CMS.

Why keeping only popular parts of ACA won’t work

While President-elect Donald Trump may be offering a compromise on the Affordable Care Act (ACA) by keeping its ban on insurers denying coverage based on preexisting conditions, it’s doomed to fail if insurers can charge sick people more.

Thumbnail

Educational CPR simulation offers feedback to users

Gaumard Scientific Company, producers of educational simulators for more than 60 years, has introduced and demonstrated the OMNI 2, its newest CPR trainer that combines value-priced simulators with a touch-screen platform.

Genalyte brings blood testing to patient's front door

Genalyte, a clinical diagnostics company, has introduced clinical abstracts for the Maverick Detection System, which could produce results more quickly and offer remote testing for patients.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.